Illingworth Research Increases Clinical Trial Efficiency and Compliance with Montrium’s eTMF Connect Solution
Illingworth Research Group has selected the Montrium eTMF Connect solution to streamline global clinical operations and centralize collaboration with sponsors and sites. This Connect solution changes how sponsors and partners work together through providing fast, direct access to content and data. Illingworth along with other organizations can reap the benefits by accessing and collaborating on the content in real-time, thus increasing clinical trial efficiency.
Read the full release here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Expands Farapulse PFA Approval to Persistent AF After Strong ADVANTAGE AF Trial Results
July 7th 2025Boston Scientific’s Farapulse Pulsed Field Ablation System is now approved for treating persistent atrial fibrillation, following 12-month data from the ADVANTAGE AF trial showing strong safety, high freedom from AF, and no major complications.
